Mount Yale Investment Advisors’s Guardant Health GH Stock Holding History

Mount Yale Investment Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$404K	Buy	+2,692	New	+$293K	0.01%	863
2026 Q1	–	Sell	-2,501	Closed	-$255K	–	1107
2025 Q4	$255K	Buy	+2,501	New	+$224K	0.01%	632
2021 Q3	–	Sell	-1,807	Closed	-$224K	–	473
2021 Q2	$224K	Hold	1,807	–	–	0.03%	388
2021 Q1	$276K	Sell	1,807 -11	-0.6%	-$1.66K	0.04%	332
2020 Q4	$234K	Sell	1,818 -9	-0.5%	-$1.04K	0.03%	350
2020 Q3	$204K	Sell	1,827 -982	-35%	-$89.8K	0.03%	330
2020 Q2	$228K	Buy	+2,809	New	+$226K	0.04%	292

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mount Yale Investment Advisors's GH Position: Q2 2026 in Review

Mount Yale Investment Advisors opened a new position in Guardant Health (GH) in Q2 2026: 2,692 shares worth $404K. The stake represents 0.01% of the portfolio and ranks #863 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in GH as recently as Q4 2025.

Mount Yale Investment Advisors first reported a position in GH in Q2 2020 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Mount Yale Investment Advisors held 2,692 shares of Guardant Health worth $404K as of Q2 2026.
Guardant Health was a new Mount Yale Investment Advisors position in Q2 2026.
Guardant Health made up 0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #863 holding.
Mount Yale Investment Advisors first reported a position in Guardant Health in Q2 2020 and has held it in 7 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.